日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma.

奥沙利铂可诱导肝癌细胞焦亡,并增强机体对肝细胞癌的抗肿瘤免疫力

Deng Min, Zhao Rongce, Zou Hao, Guan Renguo, Wang Jiongliang, Lee Carol, He Benyi, Zhou Jing, Li Shaohua, Wei Wei, Cai Hao, Guo Rongping

Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma

比较PD-L1抗体与PD-1抗体联合乐伐替尼和肝动脉灌注化疗治疗不可切除肝细胞癌的疗效

Li, Shaohua; Mei, Jie; Zhao, Rongce; Zhou, Jing; Wang, Qiaoxuan; Lu, Lianghe; Li, Jibin; Zheng, Lie; Wei, Wei; Guo, Rongping

Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma

乐伐替尼联合度伐利尤单抗及肝动脉灌注化疗治疗不可切除的肝内胆管癌的疗效和安全性

Zhao, Rongce; Zhou, Jing; Miao, Zhaoxia; Xiong, Xinhao; Wei, Wei; Li, Shaohua; Guo, Rongping

Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma

α-FAtE评分在肝细胞癌局部区域免疫治疗预后预测中的应用

Zheng, Zehao; Guan, Renguo; Zhao, Rongce; Gan, Junyu; Xiong, Xinhao; Zou, Jing-Wen; Li, Shaohua; Wang, Qiaoxuan; Wei, Wei; Mei, Jie; Guo, Rongping

FOLFOX-Based Hepatic Arterial Infusion Chemotherapy with Sequential Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Large Hepatocellular Carcinoma: A Single-Center Retrospective Cohort Study

FOLFOX方案联合肝动脉灌注化疗和序贯药物洗脱微球经动脉化疗栓塞术治疗不可切除的大型肝细胞癌:单中心回顾性队列研究

Zhao, Rongce; Zhou, Jing; Zheng, Zehao; Xiong, Xinhao; Wang, Qiaoxuan; Li, Shaohua; Wei, Wei; Guo, Rongping

Hepatic arterial infusion chemotherapy in combination with lenvatinib and durvalumab versus standard first-line treatment gemcitabine and cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma

晚期肝内胆管癌中,肝动脉灌注化疗联合乐伐替尼和度伐利尤单抗与标准一线治疗吉西他滨和顺铂联合度伐利尤单抗的疗效比较

Zhao, Rongce; Zhou, Jing; Xiong, Xinhao; Wang, Qiaoxuan; Liu, Chunxiao; Wei, Wei; Li, Shaohua; Guo, Rongping

Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy

接受程序性细胞死亡蛋白-1靶向免疫疗法治疗的晚期肝内胆管癌患者的真实世界疗效

Deng, Min; Li, Shaohua; Wang, Qiaoxuan; Zhao, Rongce; Zou, Jingwen; Lin, Wenping; Mei, Jie; Wei, Wei; Guo, Rongping

Antitumor immunity induced by VE-cadherin modified DC vaccine

VE-钙黏蛋白修饰的DC疫苗诱导的抗肿瘤免疫

Zhou, Jing; Xi, Yufeng; Mu, Xiyan; Zhao, Rongce; Chen, Hongdou; Zhang, Li; Wu, Yang; Li, Qiu